{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:21:18Z","timestamp":1791091278903,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T00:00:00Z","timestamp":1328227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00436-012-2823-z","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T14:33:06Z","timestamp":1328193186000},"page":"223-230","source":"Crossref","is-referenced-by-count":44,"title":["Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani"],"prefix":"10.1007","volume":"111","author":[{"given":"Dhiraj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasundhra","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Kulshrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra Singh","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Salotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,3]]},"reference":[{"key":"2823_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0031182010001095","volume":"138","author":"V Adaui","year":"2011","unstructured":"Adaui V, Schnorbusch K, Zimic M, Guti\u00e9rrez A, Decuypere S, Vanaerschot M, DE Doncker S, Maes I, Llanos-Cuentas A, Chappuis F, Ar\u00e9valo J, Dujardin JC (2011) Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology 138:183\u2013193","journal-title":"Parasitology"},{"key":"2823_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/14787210.4.2.187","volume":"4","author":"MD Boer","year":"2006","unstructured":"Boer MD, Davidson RN (2006) Treatment options for visceral leishmaniasis. Expert Rev Anti Infect Ther 4:187\u2013197","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2823_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"SL Croft","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19:111\u2013126","journal-title":"Clin Microbiol Rev"},{"key":"2823_CR4","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/AAC.49.11.4616-4621.2005","volume":"49","author":"S Decuypere","year":"2005","unstructured":"Decuypere S, Rijal S, Yardley V, De Doncker S, Laurent T, Khanal B, Chappuis F, Dujardin JC (2005) Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother 49:4616\u20134621","journal-title":"Antimicrob Agents Chemother"},{"key":"2823_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0031182007003782","volume":"135","author":"S Decuypere","year":"2008","unstructured":"Decuypere S, Vanaerschot M, Rijal S, Yardley V, Maes L, de Doncker S, Chappuis F, Dujardin JC (2008) Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation. Parasitology 135:183\u2013194","journal-title":"Parasitology"},{"key":"2823_CR6","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/AAC.49.5.1988-1993.2005","volume":"49","author":"K Fadili El","year":"2005","unstructured":"El Fadili K, Messier N, Leprohon P, Roy G, Guimond C, Trudel N, Saravia NG, Papadopoulou B, L\u00e9gar\u00e9 D, Ouellette M (2005) Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrob Agents Chemother 49:1988\u20131993","journal-title":"Antimicrob Agents Chemother"},{"key":"2823_CR7","doi-asserted-by":"crossref","first-page":"31010","DOI":"10.1074\/jbc.M403959200","volume":"279","author":"B Gourbal","year":"2004","unstructured":"Gourbal B, Sonuc N, Bhattacharjee H, Legare D, Sundar S, Ouellette M, Rosen BP, Mukhopadhyay R (2004) Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem 279:31010\u201331017","journal-title":"J Biol Chem"},{"key":"2823_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-6851(00)00187-0","volume":"108","author":"A Haimeur","year":"2000","unstructured":"Haimeur A, Brochu C, Genest P, Papadopoulou B, Ouellette M (2000) Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae. Mol Biochem Parasitol 108:131\u2013135","journal-title":"Mol Biochem Parasitol"},{"key":"2823_CR9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","volume":"53","author":"D Kumar","year":"2009","unstructured":"Kumar D, Kulshrestha A, Singh R, Salotra P (2009) In vitro susceptibility of field isolates of Leishmania donovani to miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity. Antimicrob Agents Chemother 53:835\u2013838","journal-title":"Antimicrob Agents Chemother"},{"key":"2823_CR10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2010.03716.x","volume":"70","author":"A Kumar","year":"2010","unstructured":"Kumar A, Sisodia B, Misra P, Sundar S, Shasany AK, Dube A (2010) Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani. Br J Clin Pharmacol 70:609\u2013617","journal-title":"Br J Clin Pharmacol"},{"key":"2823_CR11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","volume":"180","author":"R Lira","year":"1999","unstructured":"Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D (1999) Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 180:564\u2013567","journal-title":"J Infect Dis"},{"key":"2823_CR12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.2008.79.69","volume":"79","author":"M Maharjan","year":"2008","unstructured":"Maharjan M, Singh S, Chatterjee M, Madhubala R (2008) Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani. Am J Trop Med Hyg 79:69\u201375","journal-title":"Am J Trop Med Hyg"},{"key":"2823_CR13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2007.76.681","volume":"76","author":"MK Mittal","year":"2007","unstructured":"Mittal MK, Rai S, Ashutosh R, Gupta S, Sundar S, Goyal N (2007) Characterization of natural antimony resistance in Leishmania donovani isolates. Am J Trop Med Hyg 76:681\u2013688","journal-title":"Am J Trop Med Hyg"},{"key":"2823_CR14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jac\/dkl494","volume":"59","author":"A Mukherjee","year":"2007","unstructured":"Mukherjee A, Padmanabhan PK, Singh SM, Roy G, Girard I, Chatterjee M, Ouellette M, Madhubala R (2007) Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother 59:204\u2013211","journal-title":"J Antimicrob Chemother"},{"key":"2823_CR15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2958.2009.06907.x","volume":"74","author":"A Mukherjee","year":"2009","unstructured":"Mukherjee A, Roy G, Guimond C, Ouellette M (2009) The gamma-glutamylcysteine synthetase gene of Leishmania is essential and involved in response to oxidants. Mol Microbiol 74:914\u2013927","journal-title":"Mol Microbiol"},{"key":"2823_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","volume":"7","author":"M Ouellette","year":"2004","unstructured":"Ouellette M, Drummelsmith J, Papadopoulou B (2004) Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resistant Update 7:257\u2013266","journal-title":"Drug Resistant Update"},{"key":"2823_CR17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","volume":"9","author":"FJ P\u00e9rez-Victoria","year":"2006","unstructured":"P\u00e9rez-Victoria FJ, S\u00e1nchez-Ca\u00f1ete MP, Seifert K, Croft SL, Sundar S, Castanys S, Gamarro F (2006) Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use. Drug Resist Updat 9:26\u201339","journal-title":"Drug Resist Updat"},{"key":"2823_CR18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","volume":"193","author":"R Rojas","year":"2006","unstructured":"Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG (2006) Resistance to antimony and treatment failure in human Leishmania Viannia infection. J Infect Dis 193:1375\u20131383","journal-title":"J Infect Dis"},{"key":"2823_CR19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1086\/377133","volume":"188","author":"N Singh","year":"2003","unstructured":"Singh N, Singh RT, Sundar S (2003) Novel mechanism of drug resistance in kala azar field isolates. J Infect Dis 188:600\u2013607","journal-title":"J Infect Dis"},{"key":"2823_CR20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/505079","volume":"194","author":"R Singh","year":"2006","unstructured":"Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P (2006) Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. J Infect Dis 194:302\u2013306","journal-title":"J Infect Dis"},{"key":"2823_CR21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijantimicag.2010.03.012","volume":"36","author":"R Singh","year":"2010","unstructured":"Singh R, Kumar D, Duncan R, Nakhasi HL, Salotra P (2010) Over expression of histone H2A modulates drug susceptibility in L. donovani parasites. Int J Antimicrob Agents 36:50\u201357","journal-title":"Int J Antimicrob Agents"},{"key":"2823_CR22","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/JCM.42.4.1739-1741.2004","volume":"42","author":"G Sreenivas","year":"2004","unstructured":"Sreenivas G, Raju BV, Singh R, Selvapandiyan A, Duncan R, Sarkar D, Nakhasi HL, Salotra P (2004a) DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal leishmaniasis in humans. J Clin Microbiol 42:1739\u20131741","journal-title":"J Clin Microbiol"},{"key":"2823_CR23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exppara.2004.03.011","volume":"106","author":"G Sreenivas","year":"2004","unstructured":"Sreenivas G, Singh R, Selvapandiyan A, Negi NS, Nakhasi HL, Salotra P (2004b) Arbitrary-primed PCR for genomic fingerprinting and identification of differentially regulated genes in Indian isolates of Leishmania donovani. Exp Parasitol 106:110\u2013118","journal-title":"Exp Parasitol"},{"key":"2823_CR24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","volume":"6","author":"S Sundar","year":"2001","unstructured":"Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6:849\u2013854","journal-title":"Trop Med Int Health"},{"key":"2823_CR25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","volume":"31","author":"S Sundar","year":"2000","unstructured":"Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PC, Murray HW (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: report from the centre of the Indian epidemic. Clin Infect Dis 31:1104\u20131106","journal-title":"Clin Infect Dis"},{"key":"2823_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4269\/ajtmh.2002.66.143","volume":"66","author":"S Sundar","year":"2002","unstructured":"Sundar S, Jha TK, Thakur CP, Mishra M, Singh VR, Buffels R (2002) Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. Am J Trop Med Hyg 66:143\u2013146","journal-title":"Am J Trop Med Hyg"},{"key":"2823_CR27","doi-asserted-by":"crossref","first-page":"e904","DOI":"10.1371\/journal.pntd.0000904","volume":"4","author":"R t'Kindt","year":"2010","unstructured":"t'Kindt R, Scheltema RA, Jankevics A, Brunker K, Rijal S, Dujardin JC, Breitling R, Watson DG, Coombs GH, Decuypere S (2010) Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis 4:e904","journal-title":"PLoS Negl Trop Dis"},{"key":"2823_CR28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.meegid.2010.05.006","volume":"10","author":"DC Torres","year":"2010","unstructured":"Torres DC, Adaui V, Ribeiro-Alves M, Romero GA, Ar\u00e9valo J, Cupolillo E, Dujardin JC (2010) Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes. Infect Genet Evol 10:727\u2013733","journal-title":"Infect Genet Evol"},{"key":"2823_CR29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1074\/mcp.M600319-MCP200","volume":"6","author":"B Vergnes","year":"2007","unstructured":"Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J, Ouellette M (2007) A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics 6:88\u2013101","journal-title":"Mol Cell Proteomics"},{"key":"2823_CR30","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijpara.2007.04.008","volume":"37","author":"M Wiese","year":"2007","unstructured":"Wiese M (2007) Leishmania MAP kinases\u2014familiar proteins in an unusual context. Int J Parasitol 37:1053\u20131062","journal-title":"Int J Parasitol"},{"key":"2823_CR31","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/507710","volume":"194","author":"V Yardley","year":"2006","unstructured":"Yardley V, Ortuno N, Llanos-Cuentas A, Chappuis F, Doncker SD, Ramirez L, Croft S, Arevalo J, Adaui V, Bermudez H, Decuypere S, Dujardin JC (2006) American tegumentary leishmaniasis: is antimonial treatment outcome related to parasite drug susceptibility? J Infect Dis 194:1168\u20131175","journal-title":"J Infect Dis"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-012-2823-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-012-2823-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-012-2823-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T04:49:26Z","timestamp":1561265366000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-012-2823-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["2823"],"URL":"https:\/\/doi.org\/10.1007\/s00436-012-2823-z","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,3]]}}}